Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015

JAMA. 2018 Jun 5;319(21):2231-2233. doi: 10.1001/jama.2018.5616.

Abstract

This study uses US Department of Veterans Affairs (VA) data to characterize trends in the use of watchful waiting and active surveillance as strategies for managing low-risk prostate cancer in US veterans from 2005 through 2015.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Conservative Treatment / statistics & numerical data*
  • Conservative Treatment / trends
  • Delivery of Health Care, Integrated
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / therapy*
  • Risk Factors
  • United States
  • United States Department of Veterans Affairs
  • Veterans
  • Watchful Waiting

Substances

  • Prostate-Specific Antigen